Lixisenatide (acetate), CAS [[1997361-87-1]]

Produktübersicht

• Artikelname: Lixisenatide (acetate), CAS [[1997361-87-1]]
• Artikelnummer: MCE-HY-P0119A
• Hersteller Artikelnummer: HY-P0119A
• Alternativnummer: MCE-HY-P0119A-10MG,MCE-HY-P0119A-5MG,MCE-HY-P0119A-1MG
• Hersteller: MedchemExpress
• Kategorie: Proteine/Peptide

Produktbeschreibung

Lixisenatide acetate is a glucagon-like peptide-1 (GLP-1) receptor agonist. Lixisenatide acetate inhibits the inflammatory response through down regulation of pro-inflammatory cytokines, and suppresses of the Akt-MEK1/2 signaling pathway. Lixisenatide acetate can inhibit oxidative stress, mitochondrial dysfunction and apoptosis. Lixisenatide acetate can be used for the researches of inflammation, metabolic disease, neurological disease and cardiovascular disease, such as rheumatoid arthritis, diabetes, Alzheimers disease and atherosclerosis[1][2][3][4][5][6].

Produkteigenschaften

• Molekulargewicht: 5218.79
• Reinheit: 99.65
• CAS Nummer: [1997361-87-1]
• Formel: C215H347N61O65S.6C2H4O2
• Target-Kategorie: Akt,Apoptosis,GLP Receptor,MEK,MMP,Reactive Oxygen Species (ROS)

Anwendungsbeschreibung

• Anwendungsbeschreibung: Peptides